Corren J - Search Results

1

Parnes JR, Molfino NA, Colice G, Martin U, Corren J, Menzies-Gow A. Parnes JR, et al. Among authors: corren j. J Asthma Allergy. 2022 Jun 3;15:749-765. doi: 10.2147/JAA.S275039. eCollection 2022. J Asthma Allergy. 2022. PMID: 35685846 Free PMC article. Review.

2

Small airways disease in asthma.

Corren J. Corren J. Curr Allergy Asthma Rep. 2008 Nov;8(6):533-9. doi: 10.1007/s11882-008-0097-4. Curr Allergy Asthma Rep. 2008. PMID: 18940146 Review.

3

Role of interleukin-13 in asthma.

Corren J. Corren J. Curr Allergy Asthma Rep. 2013 Oct;13(5):415-20. doi: 10.1007/s11882-013-0373-9. Curr Allergy Asthma Rep. 2013. PMID: 24026573 Review.

4

Tezepelumab in Adults with Uncontrolled Asthma.

Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R. Corren J, et al. N Engl J Med. 2017 Sep 7;377(10):936-946. doi: 10.1056/NEJMoa1704064. N Engl J Med. 2017. PMID: 28877011 Free article. Clinical Trial.

5

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial.

Menzies-Gow A, Corren J, Bel EH, Maspero J, Heaney LG, Gurnell M, Wessman P, Martin UJ, Siddiqui S, Garcia Gil E. Menzies-Gow A, et al. Among authors: corren j. ERJ Open Res. 2019 Sep 25;5(3):00009-2019. doi: 10.1183/23120541.00009-2019. eCollection 2019 Jul. ERJ Open Res. 2019. PMID: 31579676 Free PMC article.

6

Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline.

Bourdin A, Papi AA, Corren J, Virchow JC, Rice MS, Deniz Y, Djandji M, Rowe P, Pavord ID. Bourdin A, et al. Among authors: corren j. Allergy. 2021 Jan;76(1):269-280. doi: 10.1111/all.14611. Epub 2020 Oct 21. Allergy. 2021. PMID: 33010038 Free PMC article.

7

Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY.

Corren J, Garcia Gil E, Griffiths JM, Parnes JR, van der Merwe R, Sałapa K, O'Quinn S. Corren J, et al. Ann Allergy Asthma Immunol. 2021 Feb;126(2):187-193. doi: 10.1016/j.anai.2020.10.008. Epub 2020 Oct 23. Ann Allergy Asthma Immunol. 2021. PMID: 33169672 Free article. Clinical Trial.

8

Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study.

Corren J, Karpefors M, Hellqvist Å, Parnes JR, Colice G. Corren J, et al. J Asthma Allergy. 2021 Jan 11;14:1-11. doi: 10.2147/JAA.S286036. eCollection 2021. J Asthma Allergy. 2021. PMID: 33469316 Free PMC article.

9

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study.

Emson C, Corren J, Sałapa K, Hellqvist Å, Parnes JR, Colice G. Emson C, et al. Among authors: corren j. J Asthma Allergy. 2021 Feb 3;14:91-99. doi: 10.2147/JAA.S288260. eCollection 2021. J Asthma Allergy. 2021. PMID: 33568920 Free PMC article.

10

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, Brightling CE, Griffiths JM, Hellqvist Å, Bowen K, Kaur P, Almqvist G, Ponnarambil S, Colice G. Menzies-Gow A, et al. Among authors: corren j. N Engl J Med. 2021 May 13;384(19):1800-1809. doi: 10.1056/NEJMoa2034975. N Engl J Med. 2021. PMID: 33979488 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page